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Abstract 18 
 19 
This paper reports the first application of surface enhanced Raman chemical imaging on 20 
pharmaceutical tablets containing the active ingredient (API) in very low concentrations.  21 
Taking advantage of the extremely intensive Raman signals in the presence of silver colloids, 22 
image aquisition time was radically decreased. Moreover, the investigation of drug 23 
distribution below the detection limit of regular micro-Raman spectrometry was made 24 
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feasible. The characteristics of different manufacturing technologies could be revealed at very 25 
low API concentrations by using chemometric methods for processing and evaluating the 26 
large number of varying spectra provided with this imaging method. 27 
 28 
1. Introduction 29 
 30 
Surface-enhanced Raman spectroscopy (SERS), based on the phenomenon known as 31 
surface enhanced Raman scattering, has been gaining particular attention in pharmaeutical 32 
research in the recent years [1-3]. Using this technique, the presence of certain compounds 33 
(having appropriate molecular structure) can be detected at extremely low concentrations 34 
[4,5] and this feature makes Raman spectroscopy capable of analyzing trace amounts of such 35 
analytes. Therefore the technique has become very important in pharmaceutical and biological 36 
analysis, while applications in other fields are continuously expanding as well [6,7].  37 
In spite of the rapid expansion of the application of SERS technique, its combination 38 
with Raman chemial imaging (R-CI) has just come into focus in the recent years [8-13]. This 39 
combination results in a special imaging method which is based on the selective detection of 40 
SERS active points of the scanned surface. Surface enhanced Raman chemical imaging (SER-41 
CI) has been successfully applied in certain territories of biomedical science, such as cell 42 
investigations [10] or bacterial mixture identification [11]. SER-CI has also been combined 43 
with atomic force microscopy resulting in a promising imaging technique called tip enhanced 44 
Raman spectroscopy [12] which has been shown to have great potential in semiconductor 45 
technologies [13]. 46 
The fight against illegal and counterfeit products is a continuously growing issue of 47 
high importance nowadays on the pharmaceutical and black markets [14-16]. Work has been 48 
started recently to find the advantages of SERS in the investigation of pharmaceutical and 49 
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illegal tablets [17]. The potential of its combination with chemical imaging of tablets (their 50 
outer or broken surface), however, has not yet been explored in either the field of 51 
pharmaceutical technology, or in forensic applications (to the authors best knowledge). 52 
While the non-imaging SERS technique focuses only on the detection of an active 53 
ingredient (or a similar compound such as an illegal drug), one of the most promising 54 
application of SER-CI is the spatial mapping of drug distribution in the investigated tablets. 55 
One of the main goals of R-CI in pharmaceutical technology is to understand the 56 
characteristics of drug dissolution and other physicochemical features by determining the 57 
distribution of constituents within a tablet. In the course of forensic identification of illegal 58 
tablets, the same analysis can lead to the determination of the manufacturing technology or 59 
the comparison of multiple tablets to see if they had been manufactured with the same 60 
technology (i.e. possibly at the same location or lab). In the latter case, however, two 61 
problems arise: one is that the components of an illegal tablet are usually unknown; the other 62 
is that drugs are often present in very low overall concentrations. Although it can be possible 63 
to detect very low concentrations (0,025-0,1% w/w) with normal RCI as well [18,19], this is 64 
only possible if the drug, although globally present in very low concentrations, can be locally 65 
detected in the form of distinct particles. Even in such a case the other main problem is the 66 
unavoidably high overall image acquisition time due to the high number of required 67 
measurement points (pixels) and the high acquisition time to reach appropriate signal-to-noise 68 
ratio. Where the trace drug is distributed homogeneously, conventional R-CI does not offer 69 
any advantages to the bulk analysis of tablets (e.g. with non-imaging Raman or NIR 70 
spectroscopy). 71 
The present paper offers a solution to the problem of determining the spatial 72 
distribution of a trace active ingredient by combining R-CI with the SERS technique and with 73 
chemometric evaluation using multivariate curve resolution algorithms. 74 
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2. Materials and methods: 76 
 77 
2.1. Preparation of tablets 78 
 79 
Lactose monohydrate (LMH) and trisodium citrate was purchased from Sigma Aldrich 80 
Corporation. Acetylsalycilic acid (further referred to as API i.e. the active pharmaceutical 81 
ingredient), was manufactured by Richter Gedeon Plc (Hungary). Dimethyl-sulfoxide and 82 
silver-nitrate were purchased from Reanal Ltd (Hungary).  83 
„Dry technology” (D) tablets with heterogeneous drug distribution were prepared by 84 
thorough blending of API and LMH using a mortar and pestle. In order to achieve 85 
homogeneous distribution in „wet technology” (W) tablets, 2 g API-LMH blend was 86 
dissolved in 10 ml dimethyl sulfoxide and then the solvent was evaporated with vacuum 87 
distillation. 88 
API:LMH mass ratio was 1:399 in both tablet batches (i.e. tablets had 0.25% API in 89 
mass fractions).  Model tablets, each weighting 400 mg, were prepared in a Manfredi 90 
0057C00 type KBr disk press (Italy). 91 
 92 
2.2. Preparation of SERS colloids 93 
 94 
Ag nanoparticles were prepared by Lee and Meisel‟s method [20], widely used to 95 
synthesize silver for SERS substrates [21-25]. Silver-nitrate of 0,09g was dissolved in 0,5l of 96 
double distilled water. The solution was heated to boil and 10ml of 1% trisodium-citrate 97 
aqueous solution was added dropwise into to boiling solution during vigorous stirring. Boiling 98 
was continued for 10 more minutes. Finally a greenish-grey colloidal solution was obtained. 99 
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Before SER-CI measurements the suspension was concentrated, via centrifugation, by a factor 100 
of 10. 101 
 102 
2.3. Raman instrumentation: 103 
 104 
Raman mapping spectra were collected using a LabRAM system (Horiba Jobin-Yvon, 105 
Lyon, France) coupled with an external 532 nm Nd-YAG laser source (Sacher Lasertechnik, 106 
Marburg, Germany) and an Olympus BX-40 optical microscope (Olympus, Hamburg, 107 
Germany). An objective of 50× magnification was used for optical imaging and spectrum 108 
acquisition. The laser beam, after an optional intensity filter, is directed through the objective, 109 
and backscattered radiation is collected with the same objective. The collected radiation is 110 
directed through a notch filter that removes the Rayleigh photons, then through a confocal 111 
hole (1000 m) and an entrance slit (100 m) onto a grating monochromator (1800 112 
grooves/mm) that disperses the light before it reaches the CCD detector. The spectrograph 113 
was set to provide a spectral range of 550–1750 cm–1 and 3 cm–1 resolution. 114 
The outer surface of tablets were investigated (without any sample preparation) in 115 
each mapping experiment. Prior to SER-CI analysis, two types of reference maps had been 116 
taken from the tablets. The first type („background”) reference used exactly same imaging 117 
acquisition conditions as SER-CI analyses (see later) to ensure that no signals of the API (or 118 
the excipient) are detected without SERS. Such (“background”) maps, as they indeed 119 
consisted of noise only, are not shown in the paper. 120 
The second type of reference (R-CI) images were obtained with‟traditional‟ Raman 121 
imaging conditions, setting high enough acquisition time to see the signals of the ingredients 122 
and attempt to reveal the distribution of the trace API without SERS. To achieve this, 123 
spectrum acquisition time was 3 s and 20 such spectra were accumulated and averaged at each 124 
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pixel to achieve acceptable signal-to-noise ratio. The step size between adjacent pixels was 125 
increased to 200 m along both axes in order to utilize the high overall measurement time and 126 
to increase the probability of finding pixels that contain the API. As a compromise between 127 
image size and overall mapping acquisition time, the measured area on the tablet surfaces was 128 
31×31 pixels and acquisition of each of these maps took over 14 hours. 129 
For SER-CI analysis SERS colloid solution was dripped on top of the tablets and, after 130 
drying, mapping was carried out on their outer surface (i.e. without any further sample 131 
preparation to avoid alteration of the sample structure). Spectrum acquisition time in this case 132 
was 0,5 s per pixel and only 1 spectrum was measured at each point without multiple 133 
accumulation or averaging, to avoid degradation of the silver colloids. In this case, a step size 134 
of 2m was used between adjacent pixels to achieve high spatial resolution, and the 135 
investigated area was at least 49×49 pixels. The overall acquisition time for each SER-CI and 136 
„background” image (without SERS) was 20 min. For SER-CI analysis the laser power was 137 
reduced to 10% of its original value with an intensity filter for the same purpose (to avoid 138 
damage to colloids), while full power (~50 mW) was applied for the conventional R-CI 139 
investigations. 140 
To compensate the small measured area with SER-CI maps due to the low step size, 141 
three separate SER-CI maps were collected from different locations on each tablet. Multiple 142 
tablets were investigated to verify reproducibility but only one tablet of each batch is 143 
discussed in detail. 144 
 145 
 146 
2.4. Data analysis 147 
 148 
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Before chemometric evaluation, all spectra were base-line corrected using Eiler‟s 149 
asymmetric least squares method [26] with parameters of =105 and p=10-3. For comparison, 150 
the traditional approach of piece-wise linear baseline correction was also tested with manually 151 
selected baseline points. The measured spectra were then normalized to unit area in order to 152 
eliminate the intensity deviation among the measured points. The raw three-dimensional data 153 
was unfolded into a 2-dimensional matrix (for the procedure, see reference [14]). 154 
The estimation of pure component spectra from the Raman maps was carried out by 155 
multivariate curve resolution – alternating least squares (MCR-ALS [27,28]). This technique 156 
is based on the following bilinear model: 157 
X = CS
T
 + E         (Eq. 1) 158 
S
T
 (k × ) is the set of reference (pure component) spectra, X (p × ) is the matrix 159 
containing the mapping spectra, and C (p × k) contains the vectors of spectral concentrations 160 
(each row in C contains the concentrations of the k ingredients). The matrix E represents the 161 
residual noise. If the spectra of the pure components are known, the C matrix can be 162 
calculated in a straightforward way with the Classical Least Squares (CLS) calculation, using 163 
X and S
T
. This is comprehensively described in numerous papers [14-16]. If some or all of the 164 
components are unknown, MCR-ALS can be used, which itself generates both the 165 
concentration (also known as score) matrix C and pure spectrum (also known as loading) 166 
matrix S
T
 from the dataset X in an iterative manner, using an initial estimation for either C or 167 
S
T
 and appropriate physical constraints. Easy to use programs are available from the 168 
developers [27] and in commercial software [29]. All of these have internal algorithms for 169 
providing the initial estimations and the iterations afterwards, and require minimal effort from 170 
the user. Only non-negativity constraints were used in our study.  171 
The resolved loadings (i.e. estimated pure component spectra) were inspected one by 172 
one and only those loadings were chosen for further use, which carried specific (sharp) 173 
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vibrational peaks. The approach proposed here assumes that only the API is SERS active. 174 
(The rest of the loadings contained noise spikes and other disturbance factors arising due to 175 
the partial degreadation of SERS colloids in some of the pixels.) The scores corresponding to 176 
these loadings were set in descending order and a threshold was determined for each API 177 
spectrum. Those values were chosen as thresholds, which showed dominant change in API 178 
peak intensity. Pixels with an API score over this threshold were assigned the value of „1‟, i.e. 179 
to the API, while the rest were given a „0‟ value. This classification was accomplished using a 180 
Visual Basic algorithm written in-house. Then the received column vector of these binarized 181 
scores was formed back into an image matrix by using the reshape command in Matlab.  182 
In the case of R-CI investigations, MCR-ALS scores (i.e. spectral concentrations) 183 
were directly used to produce spatial distribution images, as usually done in most R-CI 184 
investigations [14-16, 30-34]. R-CI score images obtained by multivariate techniques usually 185 
do not require binarization to highlight the presence of an active ingredient, and the scores can 186 
be interpreted as estimated concentrations (unlike in the case of SER-CI where only the  187 
signal coming from SERS-active components are used and the raw scores do not hold 188 
information about the actual concentration). Preliminary studies with and without binarization 189 
yielded images with the same number of API-positive pixels, hence it was regarded as an 190 
unnecessary step for R-CI. 191 
All calculations were performed in MATLAB 7.6.0 (Mathworks, USA) with 192 
PLS_Toolbox 6.2 and MIA_Toolbox 2.5 (Eigenvector Research, USA). Other curve 193 
resolution and factor analysis methods are also available, but only MCR-ALS was used as 194 
numerous studies have proven it to be the best choice for this purpose [30-34]. 195 
Spectral concentrations of the ingredients present in the sample (further also referred 196 
to as „Raman scores‟ in order to avoid confusion with real concentrations) were computed 197 
with the same algorithm described above. 198 
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Visualization of spectra and spatial distribution maps was carried out with LabSpec 199 
5.41 (Horiba Jobin Yvon, France). The statistical properties of scores (mean, standard 200 
deviation) were computed with MATLAB. 201 
 202 
3. Results and discussion 203 
 204 
In order to demonstrate how SERS can enable the detection of traces of active 205 
ingredients in a solid product and the determination of their spatial distribution with R-CI 206 
special attention had to be paid to the selection of a suitable chemometric method . As SERS 207 
spectra usually have significant differences from the regular Raman spectrum of the same 208 
substance, the usual preprocessing methods and the conventional evaluation of images with 209 
classical least squares (CLS) are not feasible. Furthermore, Raman images tend to consist of a 210 
huge amount of measured spectra (a few thousands in our case). Therefore, a new way of 211 
evaluation, based on currently available chemometric methods, had to be developed. This 212 
study uses multivariate curve resolution – alternating least squares (MCR-ALS) for this 213 
purpose, which have already been proven to be the most efficient in the evaluation of Raman 214 
maps [30-34].  215 
 216 
3.1. R-CI investigations without SERS 217 
 218 
Conventional R-CI maps of (both known and unknown) pharmaceuticals can be 219 
evaluated in a straightforward manner by resolving an appropriate number of spectra using 220 
MCR-ALS. (CLS with the pure reference spectra would usually also be an option in the 221 
pharmaceutical practice, but not in forensics and when unknown samples are investigated.) 222 
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Figure 1 shows the spectra resolved using MCR-ALS decomposition. In order to 223 
properly estimate the number of components present in the sample, the number of spectra to 224 
be resolved has to be overestimated. Due to this overestimation, the outcome contains certain 225 
loadings, the features of which are very similar to one another and which in fact correspond to 226 
the same physicochemical component. If these small differences can be explained or are 227 
irrelevant with respect to the results, these similar loadings can be averaged to get a more 228 
accurate estimation of the pure component spectra [34]. Note in this case the number of 229 
components is known, so it would have been possible to resolve just two spectra, but the 230 
study follows the practice of investigating an unknown tablet as proposed in the literature. 231 
[33, 34]) 232 
 233 
Figure 1. 234 
 235 
The spectra of ‟D‟ (dry technology) tablet, resolved by initializing MCR-ALS with 6 236 
pseudorandom vectors, are shown in Fig. 1a. The first loading clearly belongs to API, while 237 
all the others are corresponding to the LMH. The differences among the LMH loadings are 238 
caused by polarization effects which introduce remarkable deviation in the relative intensities 239 
of certain peaks (e.g. 1084 and 851 cm
-1
). Note the peak positions are same and there is no 240 
band widening or shape alteration which would indicate different molecular or solid state 241 
structures. Lactose is known to be generally sensitive to the polarization of the laser light, 242 
while other substances show little intensity deviations owing to this phenomenon. This effect 243 
is more apparent in microscopic spectrometry, and usually occurs at high magnifications 244 
where the crystal size is larger than the irradiated sample volume. Figure 1b shows the 245 
resolved spectra of ‟W‟ (wet technology) tablet.  246 
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Figure 2 shows the spatial distribution of the API based on the MCR-ALS scores 247 
(concentrations) corresponding to the first loading.  Figure 2a shows large dark areas in the 248 
map of the ‟D‟ tablet that do not contain any API. In several points, however, a low amount of 249 
API can be detected. The distribution image of the ‟W‟ tablet (Fig. 2b) is very similar to the 250 
one of the ‟D‟ tablet, thus, the two technologies cannot be distinguished by R-CI at such low 251 
API concentration. The question remains whether the dark areas are truly free of the active 252 
ingredient or it is actually present under the R-CI limit of detection. 253 
 254 
Figure 2.  255 
 256 
 257 
3.2. Evaluation of SER-CI images 258 
 259 
The evaluation of SER-CI experiments is challenged by two main phenomena. On one 260 
hand, the spectra recorded with very short exposure time (0.5 sec) and aquisition number have 261 
a low signal-noise ratio. This has only minor effect on the evaluation, as noise is usually 262 
averaged out when the entire dataset of hundreds/thousands of spectra is processed with 263 
chemometric tools. On the other hand, SERS spectra of the same component show very high 264 
variability when microscopic imaging is used. aspirin molecules bound to silver nanoparticles 265 
can be polarized in various ways, since the shapes and sizes of silver nanoparticles prepared 266 
with Lee and Meisel‟s method are not exactly uniform [35]. (It is generally well known that 267 
the SERS effect investigated in a colloid system has particle size and particle shape 268 
dependence [17,36,37].) When samples are analyzed in a solution, using a macroscopic (non-269 
imaging) spectrometer, an average spectrum is obtained, simultaneously collecting signals 270 
from variously polarized analyte molecules. On the surface of dry samples, however, SERS 271 
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particles are immobilized and, in chemical imaging, only a small area is investigated at once, 272 
therefore no averaging occurs and the pixel-by-pixel high variablility among the SERS 273 
spectra is revealed. This results in an extreme deviation in the position, intensity and shapes 274 
of the surface-enhanced Raman-bands of the API. Due to the presence of SERS colloids, the 275 
baseline is also perturbed and varies significantly among the pixels. Consequently, neither the 276 
CLS method (using pre-defined reference spectra), nor the univariate approach with a selected 277 
peak can be used in practice to accurately determine the presence of the API via its SERS 278 
signals. Furthermore, an appropriate solution had to be found for the baseline correction as 279 
well. 280 
 281 
3.2.1. A suitable preprocessing method for SERS spectra 282 
 283 
To remove of fluorescent background from the SER-CI datasets, asymmetric least 284 
squares was used, originally developed by Eilers for preprocessing chromatograms [38]. 285 
Asymmetric least squares (not to be confused with alternating least squares in curve 286 
resolution) is derived from the Whitaker smoother [39], and is a fast and more efficient 287 
alternative to the widely popular Savitzky-Golay [40] filter. The details are comprehensibly 288 
described by its developer [26].  289 
 290 
Figure 3. 291 
 292 
Although this had been originally developed as a flexible smoothing tool, it can be just 293 
as well used to estimate a nonlinear background by „oversmoothing” peaks. The main 294 
advantage of this approach is that no wavenumbers have to be pre-selected to fit a (linear or 295 
nonlinear) curve to estimate the background, hence it is resistant to the variablility of peak 296 
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shapes and positions and to the emergence of unexpected SERS bands. Its comparison with 297 
piece-wise baseline correction is depicted on Figure 3. The quality of the baseline depends 298 
slightly on the asymmetric parameter (p) and mainly on the smoothing parameter (λ). 299 
Oversmoothing is generally carried out by using a very high (>10
4
)  value. After testing 300 
numerous combinations, their best values were determined as p = 0.001 and λ = 105. When 301 
the parameters are optimized and fixed, the baseline itself has to be separately calculated for 302 
each mapping spectrum. A Matlab algorithm, relying on Eiler‟s algorithmic functions, is 303 
provided in the Appendix in the electronic supplementary material to create a baseline-304 
corrected matrix from the input dataset. Afterwards, the same usual further steps (e.g. 305 
normalization) can be applied as in R-CI investigations. 306 
 307 
 308 
3.2.2. Evaluation of resolved spectra 309 
 310 
Appropriate preprocessing is only the first step in overcoming the challenges of SER-311 
CI. The other problem is that the variability in the SERS spectrum of the API has to be taken 312 
into consideration in the modelling. MCR-ALS curve resolution was therefore performed with 313 
an approriately high number of resolved loadings (in this case 20) to separate all independent 314 
signals from each other. The identification of these loadings was performed visually by 315 
determining whether sharp vibrational peaks are present, assuming that they originate from 316 
the API (which was true in this case, as lactose is not SERS active). It was found that only a 317 
few loadings carried typical bands belonging to the API, while others almost completely 318 
consisted of noise and interfering signals from the silver colloid. All loadings are shown in 319 
Figure SM-1 (“D” tablet) and SM-2 (“W” tablet) in the supplementary material, whereas 320 
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those corresponding to the API are summarized in Figure 4. Interfering signals from the 321 
colloid are illustrated on Figure SM-3 in the supplementary material. 322 
The loadings identified as Aspirin SERS spectra were compared with the pure acetyl-323 
salycilic acid spectrum on the Figure 4. The selected spectra were the loadings 5, 7 and 14 in 324 
the case of ‟D‟ tablet. Similarly, three loadings contained features similar to the pure API 325 
spectra (namely loadings 1, 7 and 8) for the “W” tablet. It has to be noted, that the number of 326 
the API-related loadings varied in the reproducted experiments. It can be also seen that in 327 
different SERS spectra different bands are enhanced and to various extent: in many cases, the 328 
intensities of such bands are amplified which are otherwise very weak in the conventional 329 
Raman spectrum of the API. This is why neither a univariate approach nor CLS modelling 330 
with reference spectra can be applied to evaluate the maps – instead, curve resolution 331 
algorithms (such as MCR-ALS) are needed, which can detect each spectrum that has different 332 
peak structures. Setting a high number of loadings to resolve is important to capture as many 333 
different API-related loadings as possible. (It has to be noted that using SERS colloids of 334 
uniform shape and narrow size range would most probably result in more uniform SERS 335 
spectra and a lower number of distinct API-related loadings, however, this would not provide 336 
any particular benefit for the chemometric evaluation proposed here. Using appropriate 337 
baseline correction with asymmetric least squares and data decomposition with MCR-ALS 338 
allows the use of less expensive SERS colloids or those prepared in-house, thereby notably 339 
increasing cost efficiency.) 340 
 341 
Figure 4. 342 
 343 
 344 
 345 
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3.2.3. Visualization of surface-enhanced distribution maps 346 
 347 
Along with the loadings the score vectors were also calculated, which are usually used 348 
as estimations of the concentration. In this case, they are used for determining whether an API 349 
SERS signal was detected in a pixel or not. For each SERS loading, this was carried out by 350 
sorting these score values by magnitude and finding a threshold above which the 351 
corresponding loading is identified as significantly being present. The threshold, separately 352 
for each loading, can be easily determined visually by sequentially bisectioning (“halving”) 353 
the sorted scores, and checking the corresponding spectrum on the map, in a few steps. The 354 
method is the following: (1) Take the score in the middle of the sorted score list. (2) Visually 355 
check the mapping spectrum having this score value. (3) If this spectrum has visible SERS (in 356 
this case, API) peaks, then proceed to the lower half of sorted scores and repeat the process 357 
from step (1). Otherwise, proceed to the upper half of the sorted scores and repeat from step 358 
(1). A good threshold is quickly received in n steps for a map containing up to 2
n
 pixels. After 359 
determining the score threshold for each API-related loading, all scores can be binarized 360 
based on whether they are higher (1 or “SERS-positive”) or lower (0 or “SERS-negative”) 361 
than the threshold and the pixels with SERS signals present can be counted on the Raman 362 
map. 363 
The binarized scores, each indicating if the API was detected via its SERS signal in a 364 
pixel, can be refolded to a spatial image in the same way the concentration images are usually 365 
produced. As the investigated area of a SER-CI map (60 m × 60 m) was smaller than the 366 
area covered by an R-CI reference map (200 m × 200 m), three SER-CI maps were 367 
acquired from different, randomly selected locations from both “D” and “W” tablets. This 368 
was done to ensure that different locations show the same characteristics with regards to the 369 
API distribution. Figure 5 proves that in contrast to conventional R-CI, the difference between 370 
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the dry and wet technologies can be easily recognized based on the SER-CI maps. These 371 
findings are supported by Table 1 highlighting the number of pixels with the API present. 372 
While the API was detected in a relatively small number of distinct pixels in the ‟D‟ tablet (9-373 
14%), in the case of ‟W‟ tablets the SERS signals of aspirin were detected in the vast majority 374 
of the pixels (91-98%).  375 
Table 1 shows that the number of SERS-positive pixels were consequently 8-10× more 376 
in the ‟W‟ tablets than in the ‟D‟ tablets, unambigously differentiating the wet and dry 377 
manufacturing technologies. This means that when the tablet is prepared by wet granulation, 378 
the API forms a narrow layer on the excipient particles, which cannot be detected with R-CI if 379 
the overall concentration of API is very low (0.25% in this case), but can be unambiguously 380 
detected if SERS colloid is applied on the tablet surface. 381 
 382 
Figure 5. 383 
 384 
Table 1.  385 
 386 
The traditional R-CI concentration maps, obtained with much longer measurement 387 
time, were plotted on the Figure 2, where the two manufacturing technologies could not be 388 
distinguished. The reason is that the API is under the limit of detection in the majority of 389 
pixels in the map of the W tablet. If silver colloids are used to enhance the API spectra, the 390 
presence of API is revealed in more than 90% of pixels for the “W” tablet, where a fraction of 391 
the API is homogeneously distributed throughout the whole tablet due to the wet technology. 392 
This is ten times more than the number SERS-positive pixels spectra when the tablet was 393 
prepared with a dry technology (comparing maps of approximately the same sizes). Much 394 
fewer API-positive pixels are detected by R-CI investigations, in which case the difference – 395 
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without lingering reproducibility studies – is not drastic enough to unambiguously 396 
differentiate between the two technologies. Besides, such reproducibility studies are often 397 
impossible in real-life forensic studies where only one or very few samples are available for 398 
investigation. 399 
Another advantage of the SER-CI method is the outstanding decrease of mapping 400 
acquisition time, while using the same instrumental set-up as for ordinary R-CI studies. While 401 
each R-CI measurement took over 14 hours, the overall acquisition time for a SER-CI map – 402 
with a higher number of pixels – took only 20 minutes. Even the acquisition of multiple SER-403 
CI maps will be significantly less time-consuming than ordinary R-CI, while delivering more 404 
information. 405 
It has to be noted that the model tablets in this case contained the API in the same 406 
concentration (0.25%). Some studies tend to correlate the percentage of pixels with a certain 407 
component present (i.e. the surface coverage of that component) with the overall 408 
concentration of that component in the sample [41]. It has been already shown for ordinary R-409 
CI that the surface coverage and the estimated overall concentrations depend on the 410 
manufacturing technology [42], this phenomenon is extremely amplified when SERS is used, 411 
and the maps currently cannot be processed to provide (semi-)quantitative information about 412 
the API content. Therefore further studies are required to develop a semi-quantitative method 413 
to estimate the amount of the active ingredient using SER-CI. Another drawback of the 414 
currently proposed evaluation approach to SER-CI maps is that it does not offer an automated 415 
method to determine if the SERS signals are arising from one component only or there are 416 
multiple, physicochemically different components simultaneously showing SERS spectra. As 417 
already the SERS spectra of the same component show lot of variation among pixels, further 418 
studies are needed to determine if multiple SERS-active components can be distinguished 419 
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based on their resolved loadings, to separately plot their surface coverage on the visualized 420 
images. 421 
 422 
 423 
4. Conclusions 424 
 425 
Surface enhanced chemical imaging was reported for the first time to investigate and 426 
compare drug containing tablets with trace amounts of active ingredient. The method was 427 
found suitable in the determination of the manufacturing technology even in cases where 428 
ordinary Raman mapping (without SERS) does not show any significant difference between 429 
tablets prepared with different manufacturing technologies. This broadens the opportunities to 430 
determine if multiple unknown (possibly illegal) tablets containing trace amounts of drug 431 
have been manufactured by the same or different technologies (i.e. presumably in the same 432 
location or different ones). In the present study, tablets produced with a dry (direct 433 
compression) and a wet technology (co-solution and solvent evaporation, then compression) 434 
were investigated. Combining SERS with chemical imaging enabled the detection of the 435 
active ingredient in areas where its concentration level was well below the Raman 436 
spectrometric limit of detection, thus revealing its true spatial distribution in the tablets. 437 
Furthermore, by enhancing API signals via SERS, generally a 120-fold reduction was 438 
achieved in the image aquisition time. This, of course, is only possible if the active ingredient 439 
is SERS active (and the current evaluation assumes that only one ingredient, i.e. the drug, is 440 
SERS active). 441 
Surface enhanced Raman chemical maps pose a great challenge to evaluate, due to the 442 
high variability of spectra arising from the colloid size and shape dependence of the SERS 443 
signals. When microscopic imaging of a solid sample is performed, these variances are not 444 
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averaged out as they otherwise do for bulk spectroscopic measurements. A new approach was 445 
hence developed by using asymmetric least squares preprocessing with appropriately chosen 446 
parameters to enable background estimation, followed by MCR-ALS data decomposition to 447 
find all the various SERS positive (in this case, API-related) loadings. 448 
The present study is the first step in the combined application of SERS, Raman 449 
chemical imaging, appropriate data preprocessing and chemometric evaluation in the 450 
structural characterization of tablets with trace amounts of drugs present. The proposed 451 
evaluation approach is intended to be applicable for such tablets where no prior information is 452 
available about the ingredients. SER-CI poses lots of challenges, some of which were solved  453 
here and some have to be overcome in the future, but may become a powerful tool in the 454 
investigation of unknown (possibly illegal) products. 455 
 456 
 457 
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 459 
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Figure captions 594 
 595 
Figure 1. Loadings obtained by MCR-ALS decomposition of conventional Raman chemical 596 
images of a) “D” tablet (prepared with dry technology) and b) “W” tablet (prepared with wet 597 
technology) 598 
 599 
Figure 2. Detected API signals in conventional R-CI concentration maps of a) “D” tablet (dry 600 
technology) and b) “W” tablet (wet technology) 601 
 602 
Figure 3. a) a baseline of a SERS positve spectrum estimated by Eiler‟s asymmetric least 603 
squares method. Comparison of SER-CI mapping spectra in b) raw form and after background 604 
removal using c) piece-wise linear baseline correction and d) Eiler‟s asymmetric least squares 605 
 606 
Figure 4. Selected API-related MCR-ALS loadings obtained from SER-CI datasets of ‟D‟ 607 
tablet and ‟W‟ tablet, compared to the pure API spectrum 608 
 609 
Figure 5. API distribution by SER-CI in randomly selected locations of ‟D‟ and ‟W‟ tablet 610 
 611 
 612 
Table captions 613 
 614 
Table 1. Number of pixels with detected API SERS signals 615 
 616 
Method 
’D’ tablet ’W’ tablet 
number of pixels 
with API present
1 
% of pixels with 
API present 
number of pixels 
with API present
1
 
% of pixels with 
API present 
R-CI 22 (961) 2.3% 9 (961) 0.9% 
SER-CI Area 1 332 (2401) 13.8% 2279 (2500) 91.2% 
Area 2 228 (2401) 9.5% 2358 (2500) 94.3% 
Area 3 245 (2401) 10.2% 2450 (2500) 98.0% 
1 
brackets show the overall number of pixels 
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